Aastrom Biosciences Inc. (ASTM) announced the closing of underwritten public offering, raising approximately $12.4 million in net proceeds from the sale of the units, including the partially exercised option of the over-allotment, after underwriting discounts and commissions and other offering expenses. The offering included the sale of 52,077,100 units in total at a public offering price of $0.26 per unit.
The company plans to use the net proceeds for general corporate purposes, including conducting operations and continuing to conduct clinical development programs.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.